This Week in Cardiology

CARDIOFIT; LMWH bridging in AF, ICD underuse claims; test-driving pacemakers; and the ongoing ABIM controversy are the topics reviewed by Dr John Mandrola

Dr Mandrola reviews stories on bystander CPR, the trans-fat ban, leveraging pharmacists for BP control, the Watchman device, and pulmonary-embolism-response teams.

The FDA Advisory Committee ruling on PCSK9 drugs, sitagliptin and CV risk, PPI use and MI risk, and the role of stress in heart disease are reviewed by Dr Mandrola.

IMPROVE-IT publication, percutaneous MV annuloplasty, cerebral protection during TAVR, digoxin, and remote preconditioning for renal protection are reviewed by Dr Mandrola.

Dr John Mandrola reviews PCSK9 inhibitors, the Dutch view of statins, alcohol's effects on cardiac structure, big data, BP therapy in the elderly, informed consent, and a tour of cardiology's past 20 years.

Dr John Mandrola reviews studies on FFR-CT for evaluation of chest pain, anticoagulation after AF ablation, a novel treatment protocol in the ER for patients with AF, mindfulness therapy, and shared-decision making.

From HRS 2015 in Boston, Dr Mandrola addresses MICRA pacing, LV endocardial pacing for CRT, MRI-safe ICDs, NOACs before AF ablation, Botox for AF, His-bundle pacing, ABIM-MOC and Contrave Light.

Lariat, stroke intervention in patients on NOACs, health literacy and HF, ASA dosing, fitness and AF, and informed consent during STEMI are discussed by Dr John Mandrola.

Dr John Mandrola discusses the QCOR cancellation, LVADs, gene therapy for heart failure, statins in the elderly, and hand sanitizers.

John Mandrola reviews congenital heart disease guidelines, sports and long QT, sleep apnea and AF, divorce and MI, and the Dr Oz scandal.